Key facts
- This page summarizes R. Lawrence van Horn's Form 4 filing for HARROW HEALTH, INC. (HROW).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Jun 2023, 16:30.
R. Lawrence van Horn - 21 Jun 2023 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)
- Reporting relationship
- Director
- Issuer ticker
- HROW
- Reported as of
- 21 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jun 2023, 16:30:20 UTC
- Prior SEC filing
- 19 May 2023
- Next SEC filing
- 06 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew R. Boll Attorney in Fact for R. Lawrence Van Horn
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
R. Lawrence van Horn filed Form 4 for HARROW HEALTH, INC. (HROW) on 23 Jun 2023.
Change
- Previous filing in this sequence was filed on 19 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HROW
transaction
Derivative
RSU
Award
- Transaction value
- $0
- Shares
- +7,744
- Change %
- Price
- $0.000000
- Shares after
- 7,744
- Date
- 21 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,744
- Exercise price
- $0.000000
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Restricted Stock Units were received as a compensatory award for no consideration.
Footnote F2
Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.